{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T22:50:10Z","timestamp":1768517410366,"version":"3.49.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nitric Oxide"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.niox.2023.04.001","type":"journal-article","created":{"date-parts":[[2023,4,6]],"date-time":"2023-04-06T03:11:26Z","timestamp":1680750686000},"page":"38-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The role of nitric oxide (NO) modulators in obsessive-compulsive disorder (OCD)"],"prefix":"10.1016","volume":"134-135","author":[{"given":"Nikolaos","family":"Pitsikas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.niox.2023.04.001_bib1","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. fifth ed.. Washington D.C.: American Psychiatric Publishing."},{"key":"10.1016\/j.niox.2023.04.001_bib2","first-page":"7","article-title":"Epidemiology of obsessive-compulsive disorder: a world view","volume":"58","author":"Sasson","year":"1997","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.niox.2023.04.001_bib3","doi-asserted-by":"crossref","first-page":"44 185","DOI":"10.1017\/S0033291713000470","article-title":"Age of onset in obsessive-compulsive disorder: admixture, analysis with a large sample","volume":"44","author":"Anholt","year":"2014","journal-title":"Psychol. Med."},{"key":"10.1016\/j.niox.2023.04.001_bib4","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.comppsych.2017.04.002","article-title":"Comorbidity, age of onset and suicidality in obsessive-compulsive disorder (OCD): an international collaboration","volume":"76","author":"Brakoulias","year":"2017","journal-title":"Compr. Psychiatr."},{"key":"10.1016\/j.niox.2023.04.001_bib5","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nrn3746","article-title":"Obsessive-compulsive disorder: an integrative genetic and neurobiological perspective","volume":"15","author":"Pauls","year":"2014","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.niox.2023.04.001_bib6","first-page":"1039","article-title":"Examination of free radical metabolism and antioxidant defense system elements in patients with obsessive-compulsive disorder","volume":"30","author":"Ersan","year":"2006","journal-title":"Prog. Neuropsychol."},{"key":"10.1016\/j.niox.2023.04.001_bib7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0022-3956(00)00022-4","article-title":"fMRI of neural activation with symptom provocation in unmedicated patients with obsessive-compulsive disorder","volume":"34","author":"Adler","year":"2000","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.niox.2023.04.001_bib8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1126\/science.1154433","article-title":"Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives","volume":"321","author":"Chamberlain","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.niox.2023.04.001_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1192\/S0007125000297857","article-title":"Role of serotonin in obsessive compulsive disorder","volume":"35","author":"Baumgarten","year":"1998","journal-title":"Br. J. Psychiatr. Suppl."},{"key":"10.1016\/j.niox.2023.04.001_bib10","first-page":"11","article-title":"The role of dopamine in obsessive-compulsive disorder. Preclinical and clinical evidence","volume":"65","author":"Denys","year":"2004","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.niox.2023.04.001_bib11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.pscychresns.2005.12.006","article-title":"A magnetic resonance spectroscopy investigation of obsessive-compulsive disorder and anxiety","volume":"146","author":"Whiteside","year":"2006","journal-title":"Psychiatry Res. Neuroimaging."},{"key":"10.1016\/j.niox.2023.04.001_bib12","first-page":"375","article-title":"Pharmacological treatment of obsessive-compulsive disorder","volume":"37","author":"Pittenger","year":"2014","journal-title":"Psychiatr. Clin."},{"key":"10.1016\/j.niox.2023.04.001_bib13","first-page":"1","article-title":"Obsessive-compulsive disorder","volume":"5","author":"Stein","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.niox.2023.04.001_bib14","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/mp.2009.50","article-title":"Meta-analysis of the dose-response relationship of SSRI in obsessive-compulsive disorder","volume":"15","author":"Bloch","year":"2009","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.niox.2023.04.001_bib15","first-page":"368","article-title":"Predictors of drug treatment response in obsessive-compulsive disorder","volume":"56","author":"Ravizza","year":"1995","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.niox.2023.04.001_bib16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.janxdis.2013.10.007","article-title":"Differential efficacy of cognitive-behavioral therapy and pharmacological treatments for pediatric obsessive-compulsive disorder: a meta-analysis","volume":"28","author":"Sanchez-Meca","year":"2014","journal-title":"J. Anxiety Disord."},{"key":"10.1016\/j.niox.2023.04.001_bib17","doi-asserted-by":"crossref","first-page":"e766","DOI":"10.4088\/JCP.16m11101","article-title":"Randomized, double-blind, placebo-controlled trial of N-acetylcysteine. Augmentation for treatment-resistant obsessive-compulsive disorder","volume":"78","author":"Costa","year":"2017","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.niox.2023.04.001_bib18","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/336385a0","article-title":"Endothelium-derived relaxing factor release on activation of NMDA receptors suggests a role as intercellular messenger in the brain","volume":"336","author":"Garthwaite","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.niox.2023.04.001_bib19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1042\/bj2980249","article-title":"Nitric oxide synthases in mammals","volume":"298","author":"Knowles","year":"1994","journal-title":"Biochem. J."},{"key":"10.1016\/j.niox.2023.04.001_bib20","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1073\/pnas.74.8.3203","article-title":"Nitric oxide activates guanylate cyclase and increases guanosine 3\u20195\u2019 -cyclic monophosphate levels in various tissue preparations","volume":"74","author":"Arnold","year":"1977","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.niox.2023.04.001_bib21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/978-3-540-68964-5_5","article-title":"Phosphodiesterases in the central nervous system","volume":"191","author":"Kleppisch","year":"2009","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.niox.2023.04.001_bib22","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.phrs.2017.04.011","article-title":"Epigenetics: the third pillar of nitric oxide signalling","volume":"121","author":"Socco","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.niox.2023.04.001_bib23","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.neubiorev.2006.11.001","article-title":"New perspectives on the mechanisms through which nitric oxide may affect learning and memory processes","volume":"31","author":"Edwards","year":"2007","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.niox.2023.04.001_bib24","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0092-8674(94)90269-0","article-title":"Redox signaling: nitrosylation and related target interactions of nitric oxide","volume":"78","author":"Stamler","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.niox.2023.04.001_bib25","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/bph.12217","article-title":"Biological nitric oxide signaling: chemistry and terminology","volume":"169","author":"Heinrich","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.niox.2023.04.001_bib26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.schres.2020.05.050","article-title":"Current understanding on the role of nitric oxide and therapeutic potential of NO supplementation in schizophrenia","volume":"222","author":"Oh","year":"2020","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.niox.2023.04.001_bib27","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0006-291X(88)80015-9","article-title":"Nitric oxide a cytotoxic activated macrophage effector molecule","volume":"157","author":"Hibbs","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.niox.2023.04.001_bib28","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/327524a0","article-title":"Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor","volume":"327","author":"Palmer","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.niox.2023.04.001_bib29","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0301-0082(00)00044-7","article-title":"Nitric oxide as modulator of neuronal function","volume":"64","author":"Prast","year":"2001","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.niox.2023.04.001_bib30","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.bbr.2014.06.008","article-title":"The role of nitric oxide in the object recognition memory","volume":"285","author":"Pitsikas","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.niox.2023.04.001_bib31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0014-2999(92)90759-W","article-title":"Nitric oxide induces neurotransmitter release from the hippocampal slices","volume":"220","author":"Lonart","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.niox.2023.04.001_bib32","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/syn.10076","article-title":"Regulation of striatal dopamine neurotransmission by nitric oxide: effector pathways and signalling mechanisms","volume":"44","author":"West","year":"2002","journal-title":"Synapse"},{"key":"10.1016\/j.niox.2023.04.001_bib33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.brainres.2004.01.090","article-title":"The effects of nitric oxide on striatal serotoninergic transmission involve multiple targets: an in vivo microdialysis study in the awake rat","volume":"1008","author":"Trabace","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.niox.2023.04.001_bib34","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nrn2214","article-title":"Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity","volume":"8","author":"Calabrese","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.niox.2023.04.001_bib35","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/sj.bjp.0707224","article-title":"Recent development in nitric oxide donor drugs","volume":"151","author":"Miller","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.niox.2023.04.001_bib36","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.niox.2018.04.002","article-title":"The role of nitric oxide (NO) donors in anxiety. Lights and shadows","volume":"77","author":"Pitsikas","year":"2018","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.niox.2023.04.001_bib37","first-page":"169","article-title":"Nitric oxide and anxiety, Vitam","volume":"103","author":"Gulati","year":"2017","journal-title":"Hormoon"},{"key":"10.1016\/j.niox.2023.04.001_bib38","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1471-2350-11-108","article-title":"Mutation screening of NOS1AP gene in a large sample of psychiatric patients and controls","volume":"11","author":"Delome","year":"2010","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.niox.2023.04.001_bib39","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/08039488.2016.1240230","article-title":"Neuronal nitric oxide synthase polymorphisms in obsessive-compulsive disorder","volume":"71","author":"Topaloglou","year":"2017","journal-title":"Nord. J. Psychiatr."},{"key":"10.1016\/j.niox.2023.04.001_bib40","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1440-1819.2005.01426.x","article-title":"Plasma nitrate values in patients with obsessive-compulsive disorder","volume":"39","author":"Atmaca","year":"2005","journal-title":"Psychiatr. Clin. Neurosci."},{"key":"10.1016\/j.niox.2023.04.001_bib41","doi-asserted-by":"crossref","first-page":"775","DOI":"10.3906\/sag-1503-100","article-title":"Levels of nitric oxide, asymmetric dimethyl arginine, symmetric dimethyl arginine, and L arginine in patients with obsessive-compulsive disorder","volume":"46","author":"Yilmaz","year":"2016","journal-title":"Turk. J. Med. Sci."},{"key":"10.1016\/j.niox.2023.04.001_bib42","doi-asserted-by":"crossref","first-page":"10878","DOI":"10.1523\/JNEUROSCI.0034-07.2007","article-title":"Serotonin transporter phosphorylation by cGMP-dependent protein kinase is altered by mutation associated with obsessive-compulsive disorder","volume":"27","author":"Zhang","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.niox.2023.04.001_bib43","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11064-006-9233-5","article-title":"Analysis of plasma biopterin levels in psychiatric disorders suggest a common BH4 deficit in schizophrenia and schizoaffective disorders","volume":"32","author":"Richardson","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.niox.2023.04.001_bib44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.niox.2019.07.005","article-title":"Nasal nitric oxide in relation to psychiatric status of patients with empty nose syndrome","volume":"92","author":"Fu","year":"2019","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.niox.2023.04.001_bib45","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.niox.2009.07.001","article-title":"Role of nitric oxide in obsessive-compulsive behavior and its involvement in the anti-compulsive effect of paroxetine in rats","volume":"21","author":"Umathe","year":"2009","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.niox.2023.04.001_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.niox.2022.09.001","article-title":"Effects of low doses of different nitric oxide (NO) donors in rat models of obsessive-compulsive disorder (OCD) and posttraumatic stress disorder (PTSD)","volume":"129","author":"Peristeri","year":"2022","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.niox.2023.04.001_bib47","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.kjms.2012.11.003","article-title":"Effects of agomelatine in a murine model of obsessive-compulsive disorder: interaction with meta-chlorophenylpiperazine, bicuculline and diazepam","volume":"29","author":"Bhutada","year":"2013","journal-title":"Kaohsiung J. Med. Sci."},{"key":"10.1016\/j.niox.2023.04.001_bib48","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neuropharm.2017.12.015","article-title":"Fear extinction in an obsessive-compulsive animal model: influence of sex and estrous cycle","volume":"131","author":"Reimer","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.niox.2023.04.001_bib49","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neulet.2010.06.002","article-title":"Nitric oxide is involved in the regulation of marble-burying behaviour","volume":"450","author":"Krass","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.niox.2023.04.001_bib50","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.pbb.2014.04.007","article-title":"Experimental evidence for involvement of nitric oxide in low frequency magnetic field induced obsessive compulsive disorder-like behaviour","volume":"122","author":"Salunke","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.niox.2023.04.001_bib51","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ejphar.2015.11.044","article-title":"Involvement of nitric oxide in anticompulsive-like effect of agmatine on marble-burying behaviour in mice","volume":"770","author":"Gawali","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.niox.2023.04.001_bib52","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.neuropharm.2018.10.039","article-title":"S-ketamine reduces burying behaviour: involvement of ventromedial orbitofrontal cortex and AMPA receptors","volume":"144","author":"Tosta","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.niox.2023.04.001_bib53","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jpsychires.2022.05.026","article-title":"Brain-derived neurotrophic factor as a biomarker for obsessive-compulsive disorder: a meta-analysis","volume":"151","author":"Hao","year":"2022","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.niox.2023.04.001_bib54","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bbr.2013.02.038","article-title":"Oxcarbazepine and fluoxetine protect against mouse models of obsessive compulsive disorder through modulation of cortical serotonin and creb pathway","volume":"247","author":"Arora","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.niox.2023.04.001_bib55","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.pharep.2014.12.015","article-title":"Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 2. Depression, anxiety, schizophrenia and autism","volume":"67","author":"Smaga","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.niox.2023.04.001_bib56","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s002100000370","article-title":"Regulatory role of nitric oxide over hippocampal 5-HT release in vivo","volume":"363","author":"Segieth","year":"2001","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.niox.2023.04.001_bib57","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(00)01378-1","article-title":"Nitric oxide modulates N-methyl-D-aspartate-evoked serotonin release in the raphe nuclei and frontal cortex of the freely moving rat","volume":"291","author":"Smith","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.niox.2023.04.001_bib58","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/sj.bjp.0703349","article-title":"Endogenous nitric oxide decreases hippocampal levels of serotonin and dopamine in vivo","volume":"130","author":"Wegener","year":"2000","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.niox.2023.04.001_bib59","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s12640-012-9350-7","article-title":"The anti-inflammatory effect of melatonin on methamphetamine-induced pro-inflammatory mediators in human neuroblastoma dopamine SH-SY5Y cells","volume":"23","author":"Permpoonputtana","year":"2013","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.niox.2023.04.001_bib60","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1139\/apnm-2017-0313","article-title":"Exercise training with concomitant nitric oxide synthase inhibition improved anxiogenic behavior, spatial cognition, and BDNF\/P70S6 kinase activation in 20-month-old rat","volume":"43","author":"Salehpour","year":"2018","journal-title":"Appl. Physiol. Nutr. Metabol."},{"key":"10.1016\/j.niox.2023.04.001_bib61","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.pnpbp.2019.04.007","article-title":"Activation of the TRKB receptor mediates the panicolytic-like effect of the NOS inhibitor aminoguanidine","volume":"93","author":"Ribeiro","year":"2019","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.niox.2023.04.001_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/297357","article-title":"Nitric oxide donors as neuroprotective agents after an ischemic stroke-related inflammatory reaction","author":"Godinez-Rubi","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.niox.2023.04.001_bib63","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.pbb.2008.08.021","article-title":"Co-administration of nitric oxide (NO) donors prevents haloperidol-induced orofacial dyskinesia, oxidative damage and change in striatal dopamine levels","volume":"91","author":"Bishnoi","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.niox.2023.04.001_bib64","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.brainresbull.2005.08.013","article-title":"Nitric oxide synthesis is required for exercise-induced increases in hippocampal BDNF and phosphatidylinositol 3 kinase expression","volume":"68","author":"Chen","year":"2006","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.niox.2023.04.001_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2010.01.012","article-title":"Norepinephrine and nitric oxide promote cell survival signaling in hippocampal neurons","volume":"633","author":"Patel","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.niox.2023.04.001_bib66","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1476-5381.2011.01422.x","article-title":"Translational approaches to obsessive-compulsive disorder: from animal models to clinical treatment","volume":"164","author":"Fineberg","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.niox.2023.04.001_bib67","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2174\/0929867033456792","article-title":"Brain nitric oxide and its dual role in neurodegeneration\/neuroprotection: understanding molecular mechanisms to devise drug approaches","volume":"10","author":"Contestabile","year":"2003","journal-title":"Curr. Med. Chem."}],"container-title":["Nitric Oxide"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860323000332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089860323000332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T11:30:26Z","timestamp":1736422226000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089860323000332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":67,"alternative-id":["S1089860323000332"],"URL":"https:\/\/doi.org\/10.1016\/j.niox.2023.04.001","relation":{},"ISSN":["1089-8603"],"issn-type":[{"value":"1089-8603","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of nitric oxide (NO) modulators in obsessive-compulsive disorder (OCD)","name":"articletitle","label":"Article Title"},{"value":"Nitric Oxide","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.niox.2023.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}